Products
Online Inquiry
Neomycin sulfate
Cat. No.:
0225LY-1115
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, and LC-MS.
Size:
Add to basket
Product Overview
Description:
Neomycin sulfate is a broad-spectrum aminoglycoside antibiotic that disrupts bacterial protein synthesis; it is frequently used to screen for Neo resistance genes in various cell types.
Synonym:
Framycin sulfate; 1405-10-3; Bykomycin; Neomix; Mycigient; Myciguent; Neobiotic; Neofracin; Lidamycin creme; Mycifradin-N; Neo-Rx; Quintess-N; Neo-mantle creme; Neomycine sulfate; Neomycins sulfate; New France F; Mycaifradin sulfate; Neo-Fradin; (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol;sulfuric acid
CAS No.:
1405-10-3
Compound CID:
62403
Formula:
C23H46N6O13·3H2SO4
Formula Weight:
908.87
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Neomycin sulfate can be used in antimicrobial studies to investigate the inhibition of protein synthesis in gram-negative bacteria.
Library Information
Target:
Ribosome; Phospholipase
Receptor:
30S ribosomal subunit; Phospholipase
Pathways:
Microbiology/Virology; Metabolism
Plate Number:
AOCL-15
Plate Location:
c11
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM Water
Water Max Solubility:
460 mg/mL; 506.12 mM
